All citizens and residents in target groups to get vaccines free of charge

The Ministry of Health (MOH) on Tuesday has clarified that the Sultanate has adopted a strategy for immunization against Covid 19 and the target groups are determined based on their advanced age and risk factors due to chronic diseases. Frontline workers in healthcare and education have been also given priority for vaccination, said a press statement.

MOH affirmed its commitment to providing the Covid-19 vaccine free of charge to citizens and residents of all target groups.

The Ministry stated that the national campaign for vaccination has been approved in two phases, in the first phase 30 percent of the target population will be vaccinated by the end of August 2021. While the second phase, it aims to immunize 40 percent of the targeted population, and with that 70% of targeted groups will be covered by the year-end.

MOH has contracted with several companies to achieve the goals of its national strategy for immunization.

Many private sector companies, within the framework of their social responsibility, such as those in the oil, gas, telecommunications, aviation, banking, and other sectors, have expressed their desire to support national efforts to combat the pandemic by contributing to the vaccination of employees as an extension of their contributions to support the Corona Fund.

They have been already extending support for medicines, personal protective equipment, and testing devices.

MOH stated that within the framework of the strategic partnership between the government and private health sectors, it was decided that these institutions would contribute to the national campaign for immunization within the conditions and controls set by them. These private institutions will give vaccines to their employees within their social responsibility their desire to immunize their employees within the framework of their contribution to support the Corona Fund.

The price of doses was determined on the basis of cost, shipping, storage, and logistical fees according to the type of vaccine and the requirements of the manufacturing companies.